题名

The DSM-5 Changes and Challenges in iagnosing Substance-related Disorders

并列篇名

物質相關障礙症：DSM-5診斷的改變與挑戰

作者

鄒長志(Chang-Chih Tsou)；黃三原(San-Yuan Huang)

关键词

物質相關及成癮障礙症 ； 經生物學的進步 ； substance related and addictive disorders ； eurobiological advances ； SM-5 ； D-10-CM

期刊名称

台灣精神醫學

卷期/出版年月

30卷1期（2016 / 03 / 01）

页次

6 - 22+ii

内容语文

英文
中文摘要

DSM-5於2013年五月出版，除了整合科學方面的進展外，也希望透過更簡潔與方便使用的模式來增加臨床的實用性。本文回顧從DSM-IV到DSM-5，物質相關障礙症的診斷準則改變，同時提出隨著這些改變可能會面臨的挑戰與難題。物質相關障礙症的主要準則變化包括：(A)章節名稱改變；(B)物質重新分類；(C)將物質依賴與物質濫用合併為物質使用障礙症；(D)移除物質使用障礙症診斷準則其中的法律問題；(E)病程描述的修訂；(F)物質引起的障礙症的類別更動，例如將物質引起的情緒障礙症區分為雙向情緒障礙症和憂鬱症，以及將物質引起的強迫及相關障礙症從焦慮症中獨立出來；(G)各類物質相關障礙症的部分添增或移除；(H)新增加非物質相關障礙症；(I)將仍未列入正式診斷，未來有待進一步研究的其他物質相關及成癮障礙症加入於特殊章節中。雖然DSM-5有所改善，但針對物質相關及成癮障礙症仍可能會面臨許多問題。首先，如何定義成癮行為仍無一致結論，其次，針對物質使用障礙症的新準則－渴求(craving)，目前仍有許多爭議，再者，多種物質的使用仍是臨床上一大問題。本文也回顧對於DSM-5的物質相關及成癮障礙症，ICD-9-CM到ICD-10-CM的編碼方式的演變，同時提出 DSM-5和ICD-10-CM不一致之處，以供臨床實用之便。
英文摘要

The DSM-5 that was released in May 2013, has incorporated scientifi c advances, and enhanced clinical utility with more concise, as well as been amenable in primary care. In this overview, the authors review the new classification structure and changes in diagnosing substance related disorders from the DSM-IV to the DSM-5, and point out the new challenge with the new criteria. The major changes of the DSM-5 include (A) renaming the title of chapter; (B) substance reclassification; (C) eliminating the terms of dependence and abuse, and merge the criteria of substance dependence and abuse together; (D) removing legal problem and adding craving in substance use disorder criteria; (E) course specifier modification; (F) modifying substance-specifi c disorders, such as separate substance-induced mood disorder into bipolar and depressive disorder, and separating substance-induced obsessive-compulsive disorders from anxiety disorders; (G) newly adding or removing each class diagnosis of substance related disorders; (H) adding non-substance- related disorders; and (I) adding other substance-related and addictive disorder for further study. Although the DSM-5 solves the problems of the DSM-IV, there are several challenges in diagnosing substance-related and addictive disorder: First, what behaviors could be considered as an addiction is still an ongoing debate. Second, there are some controversies on the new criterion ＂craving.＂ Third, the polysubstance is still an important issue to be discussed. In addition, this overview also covers the changes from the ICD-9-CM to the ICD-10-CM codes related to the substance-related disorder of the DSM-5, but present some discrepancies between the DSM-5 and the ICD-10-CM for more clinical conveniences and utility.
主题分类 醫藥衛生 > 社會醫學
参考文献
  1. Alavi, SS,Ferdosi, M,Jannatifard, F,Eslami, M,Alaghemandan, H,Setare, M(2012).Behavioral addiction versus substance addiction: correspondence of psychiatric and psychological views.Int J Prev Med,3,290-294.
  2. Baingana, F,al’Absi, M,Becker, AE,Pringle, B(2015).Global research challenges and opportunities for mental health and substance-use disorders.Nature,527,S172-S177.
  3. Baker, TB,Breslau, N,Covey, L,Shiffman, S(2012).DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5.Addiction,107,263-275.
  4. Black, DW(2007).A review of compulsive buying disorder.World Psychiatry,6,14-18.
  5. Budney, AJ,Hughes, JR(2006).The cannabis withdrawal syndrome.Curr Opin Psychiatry,19,233-238.
  6. Cartwright, DJ(2013).ICD-9-CM to ICD-10-CM codes: what? why? how?.Adv Wound Care,2,588-592.
  7. Chambers, RA,Taylor, JR,Potenza, MN(2003).Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability.Am J Psychiatry,160,1041-1052.
  8. Chandler, RK,Fletcher, BW,Volkow, ND(2009).Treating drug abuse and addiction in the criminal justice system: improving public health and safety.JAMA,301,183-190.
  9. Connor, JP,Gullo, MJ,White, A,Kelly, AB(2014).Polysubstance use: diagnostic challenges, patterns of use and health.Curr Opin Psychiatry,27,269-275.
  10. Conway, KP,Vullo, GC,Nichter, B(2013).Prevalence and patterns of polysubstance use in a nationally representative sample of 10th graders in the United States.J Adolesc Health,52(6),716-723.
  11. Cornelius, JR,Chung, T,Martin, C,Wood, DS,Clark, DB(2008).Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence.Addict Behav,33,1500-1505.
  12. Dackis, C,O’Brien, C(2005).Neurobiology of addiction: treatment and public policy ramifications.Nat Neurosci,8,1431-1436.
  13. First, MB,Reed, GM,Hyman, SE,Saxena, S(2015).The development of the ICD-11: clinical descriptions and diagnostic guidelines for mental and behavioural disorders.World Psychiatry,14,82-90.
  14. Fitzgerald, B,Morgan, BD(2012).DSM-5 changes on the horizon: substance use disorders.Issues Ment Health Nurs,33,605-612.
  15. Fong, TW(2006).Understanding and managing compulsive sexual behaviors.Psychiatry,3,51-58.
  16. Fowler, JS,Volkow, ND,Kassed, CA,Chang, L(2007).Imaging the addicted human brain.Sci Pract Perspect,3,4-16.
  17. Gerdner, A,Wickström, L(2015).Reliability of ADDIS for diagnoses of substance use disorders according to ICD-10, DSM-IV and DSM-5: test-retest and interitem consistency.Subst Abuse Treat Prev Policy,10,1-8.
  18. Grant, BF,Harford, TC,Muthen, BO,Yi, HY,Hasin, DS,Stinson, FS(2007).DSM-IV alcohol dependence and abuse: further evidence of validity in the general population.Drug Alcohol Depend,86,154-166.
  19. Grant, JE,Potenza, MN,Hollander, E(2006).Multicenter investigation of the opioid antagonist nalmefene in the treatment of pathological gambling.Am J Psychiatry,163,303-312.
  20. Grant, JE,Potenza, MN,Weinstein, A,Gorelick, DA(2010).Introduction to behavioral addictions.Am J Drug Alcoh Abuse,36,233-241.
  21. Hagele, C,Schlagenhauf, F,Rapp M(2015).Dimensional psychiatry: reward dysfunction and depressive mood across psychiatric disorders.Psychopharmacology,232,331-341.
  22. Hasin, DS,O’Brien, CP,Auriacombe, M(2013).DSM5 criteria for substance use disorders: recommendations and rationale.Am J Psychiatry,170,834-851.
  23. Kahler, CW,Strong, DR(2006).A Rasch model analysis of DSM-IV Alcohol abuse and dependence items in the National Epidemiological Survey on alcohol and related conditions.Alcohol Clin Exp Res,30,1165-1175.
  24. Koob, GF(2008).A role for brain stress systems in addiction.Neuron,59,11-34.
  25. Koob, GF(2009).Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory.Pharmacopsychiatry,42(Suppl 1),S32-S41.
  26. Koob, GF,Le Moal, M(2008).Addiction and the brain antireward system.Annu Rev Psychol,59,29-53.
  27. Koob, GF,Le Moal, M(2001).Drug addiction, dysregulation of reward, and allostasis.Neuropsychopharmacology,24,97-129.
  28. Koob, GF,Zorrilla, EP(2010).Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor.Curr Opin Investig Drugs,11,63.
  29. Kupfer, D(2013).The DSM-5 ‒ an interview with David Kupfer.BMC Med,11,203.
  30. Kupfer, DJ,Kuhl, EA,Wulsin, L(2013).Psychiatry’s integration with medicine: the role of DSM-5.Annu Rev Med,64,385-392.
  31. Langenbucher, JW,Labouvie, E,Martin, CS(2004).An application of item response theory analysis to alcohol, cannabis, and cocaine criteria in DSM-IV.J Abnorm Psychol,113,72-80.
  32. Manchikanti, L,Falco, FJ,Hirsch, JA(2011).Necessity and implications of ICD-10: facts and fallacies.Pain Physician,14,E405-E425.
  33. Martin, CS,Chung, T,Langenbucher, JW(2008).How should we revise diagnostic criteria for substance use disorders in the DSM-V?.J Abnorm Psychol,117,561-575.
  34. McBride, O,Adamson, G,Bunting, BP,McCann, S(2009).Characteristics of DSM-IV alcohol diagnostic orphans: drinking patterns, physical illness, and negative life events.Drug Alcohol Depend,99,272-279.
  35. Norko, MA,Fitch, WL(2014).DSM-5 and substance use disorders: clinicolegal implications.J Am Acad Psychiatry Law,42,443-452.
  36. O’Malley, KJ,Cook, KF,Price, MD,Wildes, KR,Hurdle, JF,Ashton, CM(2005).Measuring diagnoses: ICD code accuracy.Health Serv Res,40,1620-1639.
  37. Ooteman, W,Koeter, MWJ,Vserheul, R,Schippers, GM,van den Brink, W(2006).Measuring craving: an attempt to connect subjective craving with cue reactivity.Alcoh Clin Exper Res,30,57-69.
  38. Potenza, M(2015).Perspective: behavioural addictions matter.Nature,522,S62-S.
  39. Potenza, MN(2001).The neurobiology of pathological gambling.Semin Clin Neuropsychiatry,6,217-226.
  40. Potenza, MN(2014).Non-substance addictive behaviors in the context of DSM-5.Addict Behav,39,1-2.
  41. Potenza, MN(2006).Should addictive disorders include non-substance-related conditions?.Addiction,101(Suppl 1),142-151.
  42. Regier, DA,Kuhl, EA,Kupfer, DJ(2013).The DSM-5: Classification and criteria changes.World Psychiatry,12,92-98.
  43. Rennert, L,Denis, C,Peer, K,Lynch, KG,Gelernter, J,Kranzler, HR(2014).DSM-5 gambling disorder: prevalence and characteristics in a substance use disorder sample.Exp Clin Psychopharmacol,22,50-56.
  44. Reynaud, M,Karila, L,Blecha, L,Benyamina, A(2010).Is love passion an addictive disorder?.Am J Drug Alcoh Abuse,36,261-267.
  45. Rosenberg, H(2009).Clinical and laboratory assessment of the subjective experience of drug craving.Clin Psychol Rev,29,519-534.
  46. Samuel, RZ(2015).DSM-5 and substance use disorders.J Am Acad Psychiatry Law,43,262-263.
  47. Sayette, MA,Shiffman, S,Tiffany, ST,Niaura, RS,Martin, CS,Shadel, WG(2000).The measurement of drug craving.Addiction,95(Suppl 2),S189-S210.
  48. Schuckit, MA,Danko, GP,Raimo, EB(2001).A preliminary evaluation of the potential usefulness of the diagnoses of polysubstance dependence.J Stud Alcohol,62,54-61.
  49. Slutske, WS,Eisen, S,True, WR,Lyons, MJ,Goldberg, J,Tsuang, M(2000).Common genetic vulnerability for pathological gambling and alcohol dependence in men.Arch Gen Psychiatry,57,666-673.
  50. Steel, Z,Marnane, C,Iranpour, C(2014).The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013.Int J Epidemiol,43,476-493.
  51. Topaz, M,Shafran-Topaz, L,Bowles, KH(2013).ICD-9 to ICD-10: evolution, revolution, and current debates in the United States.Perspect Health Inf Manag,10,1d.
  52. Trenz, RC,Scherer, M,Harrell, P,Zur, J,Sinha, A,Latimer, W(2012).Early onset of drug and polysubstance use as predictors of injection drug use among adult drug users.Addict Behav,37,367-372.
  53. Volkow, ND,Koob, G(2015).Brain disease model of addiction: why is it so controversial?.Lancet Psychiatry,2,677-679.
  54. Volkow, ND,Koob, GF,McLellan, AT(2016).Neurobiologic advances from the brain disease model of addiction.N Engl J Med,374,363-371.
  55. Vukovic, O,Cvetic, T,Zebic, M(2008).Contemporary framework for alcohol craving.Psychiatr Danub,20,500-507.
  56. Whiteford, HA,Degenhardt, L,Rehm, J(2013).Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study.Lancet,382,1575-1586.
  57. Wise, RA(2002).Brain reward circuitry: insights from unsensed incentives.Neuron,36,229-240.
被引用次数
  1. 鄭青玫(2021)。一位近高齡男性海洛因成癮／販賣者之停藥循環歷程、家人互動關係敘說探究。輔導與諮商學報，43(3)，71-104。
print cancel